4
Changes in Ownership
Enliven Therapeutics, Inc. Filed Acc 0001415889-25-007683
CHIEF OPERATING OFFICER sold 6,667 shares at $21.44 ($142,936)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Patel Anish CHIEF OPERATING OFFICER | 2025-03-07 | Sale 10b5-1 | −6,667 | $21.44 | $142,936 | 323,310 | I: show line 1 in the form |
| Open-market sales · 6,667 sh · avg $21.44 · $142,936 | |||||||
Loading xslF345X05/form4-03112025_090341.xml…